l glutathione and rheumatoid arthritis Oxidative Stress in Arthritis: What the Future Might Hold regarding Novel Biomarkers Add‐On Therapies - Fonseca - 2019 - Oxidative Medicine and Cellular Longevity Insights in the Role of
Description
H.GramsM
[9] Stability of ADC Therapies [11] The drug component concentration in marketed ADC Therapies formulations is often below 20 mg/mL, as their high selectivity and efficacy mitigate the need for high concentrations
However, the phosphorylation level and consequently the cellular localization (cytoplasm or nucleus) of the transcription factor DAF-16, nor the expression of the DAF-16 regulated genes have been characterized ( The work of Fasseas et al
Most peptides get chewed up instantly
Saad F, Gooren L, Haider A, Yassin A
